Prof Themba Ginindza

Person

Prof Themba G Ginindza

                     

Institution

University of KwaZulu-Natal, Public Health Medicine

Telephone

+27 31 260 4214

Email

Gimindza@ukzn.ac.za

Campus

Howard

Designation

Associate Professor & Epidemiologist

Research Interests

  • Cancer Epidemiology and Cancer prevention research:  mainly HPV-related cancers, Lung cancer, Multiple Myelomas cancer, Paediatric cancers, HIV-related cancers.
  • Rationalization of HPV-related cancers screening in the Era of HIV and HPV/EBV infections.
  • Development of standardized, programmatic approach to cancer screening and the appropriate use of screening technologies.
  • Mapping & Modelling of Communicable and Non-communicable diseases with a focus on cancers related to HIV and HPV infections.
  •  Economical cost associate with Cancer
  • Cancer Therapy Innovation/Precision Medicine.

Bio sketch:

Prof Themba G. Ginindza is the Director of the Cancer & Infectious Diseases Epidemiology Research Unit (CIDERU). He is an experienced Epidemiologist who has conducted research across diverse disease spectrum, covering STIs (HPV, HIV/AIDS, CT, NG, TV, Syphilis), and cancer Epidemiology, culminating in over 60 publications in peer-reviewed international and local journals, more than half of which are in Quintile One (Q1) Ranking. He also teaches Epidemiology and supervises epidemiological research at postgraduate level. Currently, Lead PI in the Multinational Lung Cancer Control Programme (MLCCP) involving Kenya, South Africa, Tanzania, Eswatini, and more recently Lesotho and Ethiopia. He is Co-PI in the Cervical cancer Screening and Treatment algorithms study using HPV testing in Africa (CESTA) in South Africa and DUALSAVE-FGS. He is Member of the UK Research and Innovation (UKRI) International Development Peer Review College, BMC Women’s Health Journal Peer Reviewer and Global Burden of Diseases Collaborator. Additionally, member of the Expert Writing group for Palliative Care National Guideline, National Department of Health, South Africa. He member of the Expert writing Group for the National Lung cancer Screening guidelines, National Department of Health for South Africa. Also collaborated on many multidisciplinary projects in South Africa and beyond, including an ongoing HPV vaccine roll-out in Eswatini and Cervical Cancer Elimination research project. He led the Burden of HPV infection and HPV-related conditions among sexually active women in the Kingdom of ESwatini: its implications during the era of HIV epidemic research. He worked on a Clinical Trial on Cervical cancer Screening and Treatment algorithms study using HPV testing in Africa in KZN. Additionally, he developed the South African Rotavirus surveillance system; previously worked in planning, monitoring and evaluation of HIV/AIDS programmes, coordination of HIV/AIDS research projects in ESwatini and South Africa, managing and analysing hospital mining data for monitoring admissions and out-patients related to Influenza and pneumonia infections. Finally, he has an international working experience in countries like Malawi, Philippines, Kingdom of ESwatini and Finland.

List of Publications:

1.       Ngcamphalala, C., Östensson, E. & Ginindza, T.G. The economic burden of prostate cancer in Eswatini. BMC Health Serv Res 22, 483 (2022). https://doi.org/10.1186/s12913-022-07817-6

2.       Dodzo RC, Ogunsakin RE, Ginindza T. Prevalence and Associated Risk Factors for Anaemia Among Pregnant Women Attending Ante-Natal Clinic, Eswatini.  Afr J Prm Health Care Fam Med. (2022), (vol: 14, #1, a3339, https://doi.org/10.4102/phcfm.v14i1.3339

3.       Ndlovu SR, Hlongwa M, Ginindza TG. Mapping Evidence on the Risk Factors Associated with Paediatric Cancers in Sub-Saharan Africa: A Scoping Review. BMC Systematic Reviews (2022), https://doi.org/10.1186/s13643-022-01931-6

4.       Kahere M, Hlongwa M, Ginindza TG. A scoping review on the epidemiology of chronic low back pain among adults in Sub-Saharan Africa. Int. J. Environ. Res. Public Health (IJERPH) (2022), 19, 2964.  https://doi.org/10.3390/ijerph19052964

5.       Ogunsakin RE, Oluwakemi E, Ginindza T. A bibliometric analysis of the literature on Norovirus disease from 1991-2021. Int. J. Environ. Res. Public Health (IJERPH) (2022), 19, 2508. https://doi.org/10.3390/ijerph19052508

6.        Lubuzo B, Hlongwana KW, Ginindza T. Improving timely access to diagnostic and treatment services for lung cancer patients in KwaZulu-Natal, South Africa: priority-setting through nominal group techniques. Int. J. Environ. Res. Public Health (2022), 19(4), 1918, https://doi.org/10.3390/ijerph19041918

7.       Kahere M, Ginindza TG, The prevalence and psychosocial risk factors of chronic low back pain in KwaZulu-Natal. Afr J Prm Health Care Fam Med. (2022), Vol-14(1), a3134, https://doi.org/10.4102/phcfm.v14i1.3134

8.       Zondo S, Ginindza TG, Hlongwana K. The extrinsic factors affecting patient access, referral and treatment of lung cancer in selected oncology public health facilities in KwaZulu-Natal: HLS (2022), vol-10:10170 https://doi.org/10.4081/hls.2022.10170 

9.       Achoki T, GBD collaborators (Ginindza TG). Health trends, inequalities, and opportunities in South Africa’s provinces, 1990–2019: Findings from the Global Burden of Disease 2019 Study. J Epidemiol Community Health (2022), 0:1–11: http://dx.doi.org/10.1136/jech-2021-217480 

10.     Alvarez E, GBD 2019 Adolescent and Young Adult Cancer Collaborators* (Ginindza TG). The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol (2022), https://doi.org/10.1016/S1470-2045(21)00581-7

 

For more publications: ResearchGate and Google Scholar